Overview of the Drug
The drug with the NDC 51672-1381 is a topical gel formulation of Clindamycin Phosphate and Benzoyl Peroxide, marketed by Golden State Medical Supply, Inc.[1][5].
Active Ingredients and Dosage Form
- Active Ingredients: Clindamycin Phosphate and Benzoyl Peroxide
- Dosage Form: Topical Gel
- Route of Administration: Topical
Current Pricing
As of the latest data, the pricing for this drug varies based on the quantity and vendor.
Wholesale Prices
- For a 35GM package, the price ranges from $15.19 to $34.47, with a price per unit ranging from $0.434 to $0.98486 per gram[1].
- For a 50GM package, the price ranges from $97.15 to $101.96, with a price per unit ranging from $1.943 to $2.03920 per gram[1].
Price Trends and Projections
Historical Price Fluctuations
The NADAC wholesale price for Clindamycin Phosphate and Benzoyl Peroxide has fluctuated significantly, ranging from a low of $0.66322 to a high of $4.61939 per billable unit over time[2].
Future Price Projections
Given the broader pharmaceutical market trends, here are some key points to consider:
General Pharmaceutical Market Trends
- The overall drug price inflation rate for pharmaceuticals is projected to be around 3.81% for 2025, according to Vizient's summer Pharmacy Market Outlook[4].
Impact of Market Dynamics
- The increasing adoption of biologics and the outsourcing of drug development and manufacturing are expected to influence pricing strategies. However, these trends are more relevant to complex biologic drugs rather than topical gels like Clindamycin Phosphate and Benzoyl Peroxide[3].
Specific to Topical Treatments
- Topical treatments, especially those with established formulations like Clindamycin Phosphate and Benzoyl Peroxide, tend to have more stable pricing due to their generic or ANDA-approved status. This stability is less likely to be significantly impacted by the broader trends affecting more complex or innovative therapies[5].
Regulatory and Market Factors
Regulatory Environment
- The regulatory climate, while favorable for innovation, does not directly impact the pricing of established topical treatments like Clindamycin Phosphate and Benzoyl Peroxide. These drugs are already approved and widely available[3].
Supply Chain and Manufacturing
- Outsourcing of drug development and manufacturing to Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) can help reduce costs and improve efficiency. However, this is more relevant to new drug development rather than the production of established topical gels[3].
Conclusion on Price Projections
Given the stable nature of topical treatments and the specific pricing data available, here are some conclusions on price projections:
- Short-Term Stability: Prices for Clindamycin Phosphate and Benzoyl Peroxide are likely to remain relatively stable in the short term, with minimal fluctuations.
- Long-Term Trends: While the overall pharmaceutical market may see a 3.81% inflation rate, the impact on topical gels like Clindamycin Phosphate and Benzoyl Peroxide is expected to be minimal.
- Vendor and Quantity Variations: Prices will continue to vary based on the vendor and the quantity purchased, but these variations are not expected to be drastic.
"Gene and cell therapies present budgetary, operational and revenue obstacles that require health systems' multidisciplinary teams and processes to quickly identify qualified patients, access treatments and synchronize logistics for drug administration," said Carina Dolan, associate vice president, clinical oncology, pharmacoeconomics and market insights, Vizient. However, this does not directly impact the pricing of topical treatments like Clindamycin Phosphate and Benzoyl Peroxide[4].
Key Takeaways
- Stable Pricing: Clindamycin Phosphate and Benzoyl Peroxide prices are expected to remain relatively stable.
- Vendor Variations: Prices vary based on the vendor and quantity.
- Minimal Impact from Broader Trends: The drug is less likely to be significantly impacted by broader pharmaceutical market trends.
- Regulatory Stability: The regulatory environment does not indicate significant changes that would affect pricing.
FAQs
What are the active ingredients in NDC 51672-1381?
The active ingredients are Clindamycin Phosphate and Benzoyl Peroxide.
What is the dosage form of NDC 51672-1381?
The dosage form is a topical gel.
What is the current wholesale price range for NDC 51672-1381?
The price ranges from $15.19 to $101.96, depending on the quantity and vendor.
Are there any significant price fluctuations expected for NDC 51672-1381?
No, prices are expected to remain relatively stable.
How does the broader pharmaceutical market trend affect NDC 51672-1381?
The broader trends, such as the adoption of biologics and gene therapies, are not expected to significantly impact the pricing of this topical treatment.
What regulatory factors could influence the pricing of NDC 51672-1381?
The regulatory environment is stable and does not indicate significant changes that would affect pricing.
Sources
- DrugPatentWatch: Drug prices and trends for benzoyl peroxide.
- NDC List: Drug Pricing Clindamycin Phosphate And Benzoyl Peroxide Kit.
- Global Pharma Tek: Top 12 Pharmaceutical Industry Trends in 2024.
- Vizient: Vizient projects drug price inflation at 3.81%.
- FDA.report: NDC 51672-1366 - Benzoyl Peroxide.
